Skip to content

Clinical trials

Phase 4 Iron Overload trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Iron Overload Phase: Phase 4 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20072
20082
20092
20111
20132
20141
20151
20161
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
ApoPharma3
Cairo University1
Chiesi Canada Corp1
Ospedale Microcitemico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Iron Overload18
beta-Thalassemia5
Myelodysplastic Syndromes4
Thalassemia4
Anemia, Sickle Cell2
Hemosiderosis2
Anemia, Aplastic1
Anemia, Refractory1
Cardiomyopathies1
Hemochromatosis1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.